San Francisco, CA, United States of America

Matthew Hopcroft

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Avvio Medical, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Matthew Hopcroft in Ultrasound Technology

Introduction

Matthew Hopcroft is an innovative inventor based in San Francisco, CA. He has made significant contributions to the field of medical technology, particularly through his work on ultrasound devices. His inventions aim to improve medical procedures and patient outcomes.

Latest Patents

Matthew Hopcroft holds a patent for an "Ultrasound device for use with synthetic cavitation nuclei." This invention relates to an ultrasound device designed to generate a frustum-shaped beam capable of fragmenting biomineralizations within a patient's body. The device includes a transducer assembly with multiple ultrasound transducer elements and a multi-channel amplifier circuit. Each channel of the amplifier is configured to actuate a distinct subset of transducer elements, allowing for precise control over the ultrasound beam's characteristics.

Career Highlights

Matthew is currently associated with Avvio Medical, Inc., where he continues to develop innovative medical technologies. His work focuses on enhancing the effectiveness of ultrasound applications in medical treatments.

Collaborations

Matthew collaborates with notable professionals in his field, including David Bell and Daniel J Laser. Their combined expertise contributes to the advancement of medical technology and the development of new solutions.

Conclusion

Matthew Hopcroft's contributions to ultrasound technology exemplify the impact of innovation in the medical field. His work not only showcases his inventive spirit but also highlights the importance of collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…